Salivary glucose, salivary interleukin-18, glycemic control, and periodontal status in patients with type 2 diabetes mellitus
Issued Date
2025-12-01
Resource Type
eISSN
20452322
Scopus ID
2-s2.0-105020749844
Pubmed ID
41184479
Journal Title
Scientific Reports
Volume
15
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Scientific Reports Vol.15 No.1 (2025)
Suggested Citation
Techatanawat S., Puangmaliwan P., Thanathornwong B., Chairatvit K., Bhattarai B.P., Khovidhunkit W., Khovidhunkit S.o.P. Salivary glucose, salivary interleukin-18, glycemic control, and periodontal status in patients with type 2 diabetes mellitus. Scientific Reports Vol.15 No.1 (2025). doi:10.1038/s41598-025-22311-9 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/113027
Title
Salivary glucose, salivary interleukin-18, glycemic control, and periodontal status in patients with type 2 diabetes mellitus
Corresponding Author(s)
Other Contributor(s)
Abstract
This study aimed to investigate the relationships among salivary glucose, IL-18, glycemic control, and periodontal status in patients with type 2 diabetes mellitus (T2DM). Seventy-five individuals were categorized according to glycemic status: systemically healthy (controls, n = 25), T2DM with controlled glycemic status (CDM, HbA1C ≤ 7%, n = 21), and T2DM with uncontrolled glycemic status (UCDM, HbA<inf>1C</inf> > 7%, n = 29). Periodontal parameters, including periodontal probing depth (PPD) were recorded. Unstimulated whole saliva samples were analyzed for glucose and IL-18 using enzymatic and ELISA assays, respectively. Pearson correlation and multiple linear regression were used to assess relationships among variables. Salivary glucose and IL-18 levels were significantly elevated in CDM and UCDM groups compared to controls. Salivary glucose levels were associated with glycated hemoglobin (β = 0.429, P < 0.001) and fasting plasma glucose (β = 0.365, P = 0.001) independent of age, sex, PPD, and salivary flow rate. Salivary glucose and IL-18 levels were associated with each other (β = 0.282, P = 0.018) independent of age, sex, PPD, and salivary flow rate. Salivary glucose may serve as a glycemic biomarker, independent of periodontal status. Salivary glucose and IL-18 levels were significantly elevated in patients with T2DM and correlated with each other.